Gideon Bollag Opna BioUSA

Time	Session

17:30 18:15	Plenary Session - From Bench to Bedside and Back: the development and FDA approval of vemurafenib for melanoma patients Title to be announced Darrin Stuart Speaker Switzerland Learnings from RAF inhibitor drug discovery Gideon Bollag Speaker USA Title to be announced KeithFlaherty Speaker USA Discussion Room P1+2+3